Clinical Trial Update: A Bioequivalence Study, Comparing Two Formulations of Ivermectin Lotion, 0.5% [Phase 1]

View source ↗

Summary

This updates the completion of a Phase 1 bioequivalence study comparing two formulations of ivermectin lotion 0.5% for head lice infestation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head Lice Infestation
• Pediculosis Capitis

Drugs mentioned

• Ivermectin Lotion 0.5% (ivermectin)

Snippet

Sponsor: Sun Pharmaceutical Industries, Inc. | Conditions: Lice; Head Lice | Phase 1 | Status: COMPLETED